Imagen de Portada

Evaluation of Point‐of‐Care Ultrasound in Paediatric Haemophilic Arthropathy: A Prospective Comparative Study With Comprehensive Ultrasound and MRI

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Caroline Rutten, Magdy Soliman, Jyoti Panwar, Arun Mohanta, Alex Zhou, Pamela Hilliard, Tammy Rayner, Ruth Weiss, Carina Man, Rahim Moineddin, Manuel Carcao, Vanessa Bouskill, Jennifer Stimec, Kevon Dindial, Deidre Tetzlaff, Victor S. Blanchette (in memoriam), Andrea S. Doria
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Haemophilia
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Haemophilic Elbow Arthropathy: Mechanisms, Management and Future Perspectives
por: Sébastien Lobet, et al.
Publicado: (2025)

Identification of Iron Overload–Associated Biomarkers in the Synovium of Haemophilic Arthropathy
por: Yi Hu, et al.
Publicado: (2025)

Acupuncture for Chronic Pain Management in Haemophilic Arthropathy: A Systematic Review
por: Andrea Demeco, et al.
Publicado: (2025)

Clinical Course of Residual Flexion Contracture After Total Knee Arthroplasty in Patients With Haemophilic Arthropathy
por: Seyed Mohammad Javad Mortazavi, et al.
Publicado: (2025)

Joint and Myofascial Manual Therapy Techniques in Haemophilic Ankle Arthropathy: A Randomized Pilot Study
por: Carlos Truque‐Díaz, et al.
Publicado: (2025)

miR‐450b‐5p is a Key Molecular Mediator in the Development of Haemophilic Arthropathy
por: Mohankumar B. Senthilkumar, et al.
Publicado: (2026)

Activities of Daily Living and Quality of Life After Orthopaedic Surgery for Haemophilic Arthropathy: A Scoping Review
por: Makoto Asaeda, et al.
Publicado: (2026)

Morphological Variations in Haemophilic Knee Arthropathy: Surgical Implications for Total Knee Arthroplasty Component Selection and Bone Preparation
por: Seyed Mohammad Javad Mortazavi, et al.
Publicado: (2025)

Interleukin‐10 Mitigates Chondrocyte Ferroptosis Associated With Haemophilic Arthropathy via Modulation of the STAT3 Signalling Pathway
por: Fudong Luo, et al.
Publicado: (2025)

Identifying hemophilia B carriers: Utility of aPTT, factor IX levels and ratios of factor IX to other Vitamin K dependent factors
por: Michael Shu, et al.
Publicado: (2024)

How much prophylaxis is enough in haemophilia?
por: Manuel Carcao, et al.
Publicado: (2024)

Identification and Analysis of Mitochondria‐Related Proteins in Haemophilic Arthritis Synovial Membranes Based on Proteomic Analysis
por: Haitao Ma, et al.
Publicado: (2025)

Radiological Stage of Hemophilic Arthropathy of Knee Does Not Correlate With Clinical Variables
por: Arman Vahabi, et al.
Publicado: (2025)

Predominance of Radiographical Femoral Component Loosening Signs in Total Knee Arthroplasty for Hemophilic Arthropathy
por: Başak Koç, et al.
Publicado: (2025)

Eptacog beta for the management of patients with haemophilia A and B with inhibitors: A European perspective
por: Wolfgang Miesbach, et al.
Publicado: (2024)

Efficacy and Safety of Aspiration and Intra‐Articular Injection of Tranexamic Acid in Acute Knee Hemarthrosis of Adult Haemophilic Patients: A Randomized Clinical Trial Study
por: Seyed Hadi Kalantar, et al.
Publicado: (2025)

Total Knee Arthroplasty in Severe Hemophilic Arthropathy With Stiff Knees(Preoperative Flexion Range of Motion ≤40°): Functional Outcomes and Long‐Term Survivorship
por: Seyed Mohammad Javad Mortazavi, et al.
Publicado: (2025)

Differences Between Sweden and Greece in Joint Outcomes Assessed by Ultrasound in Adolescents With Severe Haemophilia on Prophylaxis: Data From the PedNet Registry
por: Aikaterini Michalopoulou, et al.
Publicado: (2025)

Comprehensive Assessment of the Transition to Efanesoctocog Alfa Prophylaxis in a Paediatric Haemophilia A Cohort
por: Rubén Berrueco, et al.
Publicado: (2026)

Outcomes of Emicizumab Treatment for Haemophilia A Paediatric Patients: A Systematic Review With Meta‐Analysis
por: Konstantina Bolou, et al.
Publicado: (2025)

Family‐Borne Financial Costs of Managing Paediatric Haemophilia in a Government Facility in North India
por: Nita Radhakrishnan, et al.
Publicado: (2025)

UK Experience of Children With Inhibitors in Severe Haemophilia B: A Report by the UKHCDO Paediatric Working Party
por: Mary Mathias, et al.
Publicado: (2026)

Safety, Efficacy and Treatment Patterns of rIX‐FP in Previously Untreated Paediatric Haemophilia B Patients: A Retrospective Chart Review in Japan
por: Keiji Nogami, et al.
Publicado: (2025)

Blood Group O Does Not Increase the Risk of Inhibitors in Severe Haemophilia A: Data from the PedNet Study Group
por: Marloes de Kovel, et al.
Publicado: (2025)

International Practices in Managing Preconception, Pregnancy and Childbirth in Women With Glanzmann Thrombasthenia: A Survey From the European Association of Haemophilia and Allied Disorders (EAHAD)
por: Karlijn H. G. Rutten, et al.
Publicado: (2025)

The WFH Guidelines for the Management of Haemophilia: AAV Gene Therapy, 2025
por: Glenn F. Pierce, et al.
Publicado: (2025)

International Prophylaxis Study Group (IPSG) haemophilia joint MRI scale version 2.0
por: Björn Lundin, et al.
Publicado: (2024)

Contrasting Approaches in the Implementation of GRADE Methodology in Guidelines for Haemophilia and Von Willebrand Disease
por: Mark W. Skinner, et al.
Publicado: (2024)

Developing a Two‐Sided Decision Box to Facilitate Shared Decision‐Making for Switching From Conventional to Pharmacokinetic‐Tailored Prophylaxis in Haemophilia
por: Arun Keepanasseril, et al.
Publicado: (2025)

Competence and Confidence: An Evaluation of Physiotherapists' Knowledge and Self‐Perception About Physical Activity and Exercise in Patients With Haemophilia
por: Ozge Ozkutlu, et al.
Publicado: (2025)

The Humanitarian and Medical Crisis in Palestinian Territories: The Plight of Patients With Congenital Bleeding Disorders and Health Care Under Siege
por: Alessandro Gringeri, et al.
Publicado: (2026)

HEAD‐US Score and Cartilage Biomarkers in Patients With Severe Haemophilia A Who Receive Low‐Dose Factor VIII Prophylaxis
por: Arpanan Pramualratthakarn, et al.
Publicado: (2026)

Canadian clinical experience on switching from standard half‐life recombinant factor VIII (rFVIII), octocog alfa, to extended half‐life rFVIII, damoctocog alfa pegol, in persons with haemophilia A ≥ 12 years followed in a Comprehensive Hemophilia Care Program in Canada
por: Davide Matino, et al.
Publicado: (2024)

EAHAD statement on the ISTH clinical practice guideline for treatment of congenital haemophilia A and B
por: Pratima Chowdary, et al.
Publicado: (2024)

Comprehensive laboratory assessment of lonoctocog alfa versus octocog alfa in severe haemophilia A
por: Jens Müller, et al.
Publicado: (2024)

Differences and similarities in patient‐reported outcomes among men and women with haemophilia
por: Christine L. Kempton, et al.
Publicado: (2024)

Women and girls’ participation in haemophilia clinical trials
por: Stacey A. Fedewa, et al.
Publicado: (2024)

Acquired bleeding disorders
por: Andreas Tiede, et al.
Publicado: (2024)

UK Infected Blood Inquiry–An Historical Appraisal
por: Christopher A. Ludlam
Publicado: (2026)

Monitoring Extended Half‐Life Factor VIII and IX Concentrates: Performance in Routine Clotting‐and Thrombin Generation Assays
por: An K. Stroobants, et al.
Publicado: (2026)